DE69619863D1 - Verfahren zur herstellung von anti-malaria arzneimittel - Google Patents

Verfahren zur herstellung von anti-malaria arzneimittel

Info

Publication number
DE69619863D1
DE69619863D1 DE69619863T DE69619863T DE69619863D1 DE 69619863 D1 DE69619863 D1 DE 69619863D1 DE 69619863 T DE69619863 T DE 69619863T DE 69619863 T DE69619863 T DE 69619863T DE 69619863 D1 DE69619863 D1 DE 69619863D1
Authority
DE
Germany
Prior art keywords
malaria
medicinal products
producing anti
producing
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69619863T
Other languages
English (en)
Other versions
DE69619863T2 (de
Inventor
Cletus Onwuzurike Ugwuegbulam
Edward Foy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of DE69619863D1 publication Critical patent/DE69619863D1/de
Application granted granted Critical
Publication of DE69619863T2 publication Critical patent/DE69619863T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69619863T 1995-10-13 1996-10-11 Verfahren zur herstellung von anti-malaria arzneimittel Expired - Lifetime DE69619863T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9521004.3A GB9521004D0 (en) 1995-10-13 1995-10-13 Process
PCT/EP1996/004433 WO1997013753A1 (en) 1995-10-13 1996-10-11 Process for the preparation of anti-malarial drugs

Publications (2)

Publication Number Publication Date
DE69619863D1 true DE69619863D1 (de) 2002-04-18
DE69619863T2 DE69619863T2 (de) 2002-11-21

Family

ID=10782264

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69619863T Expired - Lifetime DE69619863T2 (de) 1995-10-13 1996-10-11 Verfahren zur herstellung von anti-malaria arzneimittel

Country Status (28)

Country Link
US (1) US6479660B1 (de)
EP (1) EP0871616B1 (de)
JP (1) JP4083803B2 (de)
KR (1) KR100453256B1 (de)
CN (1) CN1147475C (de)
AR (1) AR004015A1 (de)
AT (1) ATE214372T1 (de)
AU (1) AU709333B2 (de)
BR (1) BR9611010A (de)
CA (1) CA2231633C (de)
CZ (1) CZ290380B6 (de)
DE (1) DE69619863T2 (de)
DK (1) DK0871616T3 (de)
ES (1) ES2170874T3 (de)
GB (1) GB9521004D0 (de)
HK (1) HK1016180A1 (de)
HU (1) HUP9900739A3 (de)
IL (1) IL124060A (de)
NO (1) NO313285B1 (de)
NZ (1) NZ320209A (de)
PL (1) PL186055B1 (de)
PT (1) PT871616E (de)
SA (1) SA97170574B1 (de)
SI (1) SI0871616T1 (de)
TR (1) TR199800637T2 (de)
TW (1) TW450950B (de)
WO (1) WO1997013753A1 (de)
ZA (1) ZA968550B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08276712A (ja) * 1995-04-05 1996-10-22 Masao Tsuji チュ−ブレススパイクタイヤ
GB0210150D0 (en) * 2002-05-03 2002-06-12 Smithkline Beecham Plc Process
EP1924558B1 (de) * 2005-09-12 2010-01-13 Council Of Scientific And Industrial Research Baylis-hillman-addukte mit antimalariawirkung und verfahren zu deren herstellung
WO2007127930A2 (en) * 2006-04-28 2007-11-08 Kansas State University Research Foundation Compounds affecting gap junction activity
GB0620005D0 (en) 2006-10-10 2006-11-22 Glaxo Group Ltd Compounds
US20090076072A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched tafenoquine
ES2453206B1 (es) 2013-09-25 2015-01-12 Thyssenkrupp Elevator Innovation Center, S.A. Sistema de tracción para un sistema de transporte
CN113248431A (zh) * 2021-05-21 2021-08-13 重庆医药高等专科学校 一种磷酸伯氨喹的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US4617394A (en) * 1985-10-15 1986-10-14 The United States Of America As Represented By The Secretary Of The Army 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines

Also Published As

Publication number Publication date
CN1199395A (zh) 1998-11-18
US6479660B1 (en) 2002-11-12
ZA968550B (en) 1998-04-14
KR100453256B1 (ko) 2004-12-17
WO1997013753A1 (en) 1997-04-17
IL124060A (en) 2003-07-31
ATE214372T1 (de) 2002-03-15
JP4083803B2 (ja) 2008-04-30
TR199800637T2 (xx) 1998-07-21
NO981537L (no) 1998-04-03
DK0871616T3 (da) 2002-07-01
ES2170874T3 (es) 2002-08-16
EP0871616B1 (de) 2002-03-13
DE69619863T2 (de) 2002-11-21
SA97170574B1 (ar) 2006-09-25
EP0871616A1 (de) 1998-10-21
HK1016180A1 (en) 1999-10-29
SI0871616T1 (en) 2002-12-31
NO313285B1 (no) 2002-09-09
CN1147475C (zh) 2004-04-28
KR19990064210A (ko) 1999-07-26
AU7291096A (en) 1997-04-30
PL326194A1 (en) 1998-08-31
TW450950B (en) 2001-08-21
PL186055B1 (pl) 2003-09-30
NZ320209A (en) 1999-08-30
BR9611010A (pt) 1999-07-13
HUP9900739A3 (en) 1999-11-29
AU709333B2 (en) 1999-08-26
CZ290380B6 (cs) 2002-07-17
CZ110398A3 (cs) 1998-09-16
NO981537D0 (no) 1998-04-03
AR004015A1 (es) 1998-09-30
PT871616E (pt) 2002-07-31
CA2231633A1 (en) 1997-04-17
GB9521004D0 (en) 1995-12-13
CA2231633C (en) 2006-10-03
HUP9900739A2 (hu) 1999-09-28
JPH11513399A (ja) 1999-11-16

Similar Documents

Publication Publication Date Title
DE69432186D1 (de) Verfahren zur herstellung stabiler arzneimittel
DE69621491D1 (de) Verfahren zur Herstellung von Epsilon-Caprolactam
DE59607656D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
DE59609854D1 (de) Verfahren zur herstellung von verkappten polyarylenethern
DE69615660T2 (de) Verfahren zur herstellung von lactamen
DE69619067D1 (de) Verfahren zur Herstellung von 3-Amino-2-oxo-1-Halogenpropan-Derivaten
DE59608641D1 (de) Verfahren zur Herstellung von Nikotinsäureamid
ATE187727T1 (de) Verfahren zur herstellung von imidazo- benzodiazepin-derivaten
ATE229021T1 (de) Verfahren zur herstellung von imidazochinazolinon-derivaten
DE69616513D1 (de) Verfahren zur herstellung von lagerstabilen milchprodukten
ATE303134T1 (de) Verfahren zur herstellung von flavano-lignan- zubereitungen
DE69628203D1 (de) Verfahren zur herstellung von phenylimidazolin-derivaten
ATE309230T1 (de) Verfahren zur herstellung von 2- chlorthiazolderivaten
DE69614571D1 (de) Verfahren zur herstellung von lovastatin
DE69619863T2 (de) Verfahren zur herstellung von anti-malaria arzneimittel
DE69625466D1 (de) Verfahren zur herstellung von polyethylennaphathalat
DE59604459D1 (de) Verfahren zur herstellung von carbonsäurederivaten
DE69600385T2 (de) Verfahren zur Herstellung von Aminonitropyridinen
DE69414000D1 (de) Verfahren zur herstellung von michael-additionsprodukten
DE69513008D1 (de) Verfahren zur Herstellung von Hydroxyalkoxybenzophenonen
DE69611380D1 (de) Verfahren zur herstellung von dioxoazabiclohexanderivaten
DE59605227D1 (de) Verfahren zur Herstellung von ortho-Nitro-benzonitrilen
DE59604010D1 (de) Verfahren zur Herstellung von 3-hydroxyoxetanen
DE59607076D1 (de) Verfahren zur Herstellung von 2-Amino-6-chlorphenyl-isopropylsulfan
DE59602852D1 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition